IAIM
ZYNE

International Assets Investment Management’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

International Assets Investment Management’s Portfolio ZYNE Stock Details ZYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-825
Closed -$3K – 2057
2021
Q1 		$3K Buy
825
+200
+32% +$907 ﹤0.01% 1971
2020
Q4 		$2K Buy
+625
New +$2.37K ﹤0.01% 1938

Other funds holding ZYNE

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

International Assets Investment Management's ZYNE Position: Q2 2021 in Review

International Assets Investment Management sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q2 2021, closing a stake of 825 shares — an estimated $3K sold.

International Assets Investment Management first reported a position in ZYNE in Q4 2020 and held it in 2 quarters. The position peaked at $3K in Q1 2021. 65 funds tracked by Wall St. Rank hold ZYNE as of Q2 2021.

  • International Assets Investment Management reported no remaining Zynerba Pharmaceuticals, Inc position as of Q2 2021 after selling out during the quarter.
  • International Assets Investment Management sold 825 Zynerba Pharmaceuticals, Inc shares in Q2 2021, an estimated $3K.
  • International Assets Investment Management first reported a position in Zynerba Pharmaceuticals, Inc in Q4 2020 and held it in 2 quarters.
  • International Assets Investment Management's Zynerba Pharmaceuticals, Inc position peaked at $3K in Q1 2021.
  • 65 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q2 2021.

Based on International Assets Investment Management's 13F filing for Q2 2021, filed 14 Jul 2021.